Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)
Objective: Lipoprotein(a) [Lp(a)] is an atherogenic and prothrombotic lipoprotein associated with atherosclerotic cardiovascular disease (ASCVD). We assessed the association between regular aspirin use and ASCVD mortality among individuals with versus without elevated Lp(a) in a nationally represent...
Saved in:
Main Authors: | Alexander C. Razavi (Author), LaTonia C. Richardson (Author), Fátima Coronado (Author), Omar Dzaye (Author), Harpreet S. Bhatia (Author), Anurag Mehta (Author), Arshed A. Quyyumi (Author), Viola Vaccarino (Author), Matthew J. Budoff (Author), Khurram Nasir (Author), Sotirios Tsimikas (Author), Seamus P. Whelton (Author), Michael J. Blaha (Author), Roger S. Blumenthal (Author), Laurence S. Sperling (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pooled Cohort Equations and the competing risk of cardiovascular disease versus cancer: Multi-Ethnic study of atherosclerosis
by: Seamus P. Whelton, et al.
Published: (2021) -
Coronary artery calcium and atherosclerotic cardiovascular disease risk in women with early menopause: The Multi-Ethnic Study of Atherosclerosis (MESA)
by: Jian H. Chu, et al.
Published: (2022) -
ASPIRIN FOR CARDIOVASCULAR DISEASE PREVENTION AMONG ADULTS IN THE UNITED STATES: TRENDS, PREVALENCE, AND PARTICIPANT CHARACTERISTICS ASSOCIATED WITH USE
by: Ellen Boakye, et al.
Published: (2021) -
Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34+ Bone Marrow Mononuclear Cells
by: Joseph C. Poole, et al.
Published: (2013) -
Aspirin for cardiovascular disease prevention among adults in the United States: Trends, prevalence, and participant characteristics associated with use
by: Ellen Boakye, et al.
Published: (2021)